This list is an analysis based on recent market events. It's not an investment recommendation.
About
S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a peptide-based functional skincare; Eyracure, a light-activated peptide technology that repairs damaged hair at the molecular level; and Eiratex, a biosynthetic polymer for wound healing applications. In addition, the company distributes instaQrett; skin substitutes under the EPIPROTECT brand; and BIOPAD, an ivory-white soft sponge. The company was incorporated in 2013 and is headquartered in Linköping, Sweden.
The current price of S21.F is €0 EUR — it has increased by +100% in the past 24 hours. Watch S2Medical AB stock price performance more closely on the chart.
What is S2Medical AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange S2Medical AB stocks are traded under the ticker S21.F.
Is S2Medical AB stock price growing?▼
S21.F stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year S2Medical AB has showed a +100% increase.
What is S2Medical AB market cap?▼
Today S2Medical AB has the market capitalization of 167,228
What is S2Medical AB revenue for the last year?▼
S2Medical AB revenue for the last year amounts to 2.56M EUR.
What is S2Medical AB net income for the last year?▼
S21.F net income for the last year is 850,279.07 EUR.
How many employees does S2Medical AB have?▼
As of April 07, 2026, the company has 7 employees.